Portfolio company
Dinya
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Dinya develops enzymatic DNA synthesis technology to provide rapid, custom gene-length DNA sequences for healthcare researchers and pharmaceutical manufacturers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ansa Biotech
The company develops enzymatic DNA synthesis technology to provide complex genetic sequences for biopharmaceutical researchers and life science laboratories.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Evonetix
The company develops a desktop DNA synthesis platform for researchers in synthetic biology and drug development to produce high-fidelity gene sequences.
DNA Script
This company develops benchtop enzymatic DNA synthesis instruments for life science researchers and laboratories to produce synthetic nucleic acids on demand.
Nunabio
This company develops enzymatic technology for the synthesis of complex DNA sequences for customers in the biotechnology, pharmaceutical and materials science sectors.
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
Elegen
The company manufactures synthetic DNA using cell-free technology for biopharmaceutical and healthcare customers to develop vaccines and genetic medicines.
Rewrite Therapeutics
This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.
